UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009422 |
|---|---|
| Receipt number | R000011069 |
| Scientific Title | Clinical trial of cellular immunotherapy for malignant tumor (gamma-delta T cell-based cancer immunotherapy) |
| Date of disclosure of the study information | 2012/11/28 |
| Last modified on | 2017/06/02 12:54:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/28 18:09:03 | ||
| 2 | Update | 2012/11/30 15:31:26 | Developmental phase |
|
| 3 | Update | 2013/04/18 15:33:20 | Division name TEL TEL |
|
| 4 | Update | 2013/11/28 14:02:56 | Email |
|
| 5 | Update | 2014/11/28 13:12:39 | Key inclusion criteria Key inclusion criteria Target sample size |
|
| 6 | Update | 2014/11/28 13:45:11 | Organization Division name Division name |
|
| 7 | Update | 2014/11/28 13:46:46 | Last follow-up date |
|
| 8 | Update | 2014/11/28 13:53:17 | Key inclusion criteria |
|
| 9 | Update | 2014/11/28 13:57:32 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 10 | Update | 2014/11/28 14:12:25 | Division name |
|
| 11 | Update | 2015/10/13 20:58:19 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 12 | Update | 2015/10/13 21:03:55 | Target sample size |
|
| 13 | Update | 2015/10/13 21:11:13 | Last follow-up date |
|
| 14 | Update | 2016/05/28 20:44:28 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary person or sponsor Institute Department Organization Organization Division Name of secondary funder(s) Name of secondary funder(s) |
|
| 15 | Update | 2017/06/02 12:54:32 | Recruitment status Results Results Other related information Other related information |
